AI Revolutionizes Life Sciences: Transforming Drug Discovery, Personalized Medicine, and Patient Outcome. BCC Research Study Projects a 27.9% CAGR, with Market Growth from $9.8 Billion in 2024 to $33.5 Billion by 2029

BOSTON, Sept. 26, 2024 /PRNewswire/ — “According to the latest BCC Research study, the demand for “Artificial Intelligence (AI) in Life Sciences Market” is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.”

The global artificial intelligence (AI) in the life sciences market is witnessing significant growth, driven by advancements in AI technologies and their increasing adoption across the life sciences sector. This report provides a comprehensive analysis of the market size, estimating both current and historical revenues segmented by products, applications, end users, and regions. By examining these factors, the report offers insights into the evolving landscape of AI in life sciences, highlighting key trends and regional dynamics that are shaping the future of this transformative field.

This report is particularly relevant at this moment due to the rapid advancements and accelerating adoption of artificial intelligence within the life sciences industry. As the volume and complexity of biological data continue to increase, there is a pressing need for innovative technologies that can enhance our ability to understand, diagnose, and treat various diseases. AI is at the forefront of these advancements, offering transformative potential to revolutionize healthcare by enabling more precise and efficient solutions. The global COVID-19 pandemic has further emphasized the importance of AI, highlighting its critical role in speeding up drug discovery, developing vaccines, and improving diagnostic tools. With these unprecedented challenges and opportunities, this report provides essential insights into the current state and future impact of AI in life sciences, making it a valuable resource for stakeholders seeking to navigate and capitalize on this rapidly evolving field.

Please click here for more details on “The global market for artificial intelligence (AI) in life sciences products Report.”

The following factors drive the global market for artificial intelligence (AI) in life sciences products:

Increasing Adoption of AI-Driven Solutions for Drug Discovery and Development: AI is transforming the drug discovery and development landscape by drastically cutting down the time and costs traditionally associated with these processes. Where conventional methods might take years and billions of dollars, AI can swiftly analyze large datasets to pinpoint potential drug candidates and forecast their efficacy and safety. This accelerates the preliminary stages of drug discovery, enabling researchers to concentrate on the most promising compounds. Moreover, AI aids in refining clinical trial designs, identifying appropriate patient groups, and predicting trial outcomes, further expediting the development pipeline.

Rising Need for Precision Medicine and Personalized Treatment Approaches: Precision medicine focuses on tailoring medical treatments to the unique characteristics of each patient. AI is instrumental in this process by analyzing genetic, environmental, and lifestyle factors to determine the most effective treatment strategies for individual patients. This personalized approach leads to improved patient outcomes, as therapies are specifically crafted to address the distinct aspects of a patient’s condition. Additionally, AI allows for real-time monitoring of patient responses, enabling rapid adjustments to treatment plans when needed. This level of customization is becoming increasingly vital as healthcare shifts towards more patient-centered models.

Request a sample copy of the global market for artificial intelligence (AI) in life sciences products report:

Report Synopsis

Key Interesting Facts About the global market for artificial intelligence (AI) in life sciences products:

1.  AI in Drug Discovery and Development:

• AI accelerates drug discovery by rapidly screening millions of compounds.
• It generates novel drug candidates, transforming drug development.
• Virtual clinical trials streamline research, reducing costs.

2.  AI in Precision Medicine and Medical Imaging:

• Precision medicine tailors treatments based on genetic analysis.
• AI excels in medical imaging analysis, aiding diagnoses.
• Machine learning detects subtle patterns, aiding early disease detection.

The global market for artificial intelligence (AI) in life sciences products report includes in-depth data and analysis addressing the following important queries:

1.  What is the projected market size and growth rate of Artificial Intelligence (AI) in the Life Sciences market?

• The global Artificial Intelligence (AI) In Life Sciences market was valued at $8.0 billion in 2023 and is expected to reach $33.5 billion by the end of 2029, expected to grow at a CAGR of 27.9% from 2024 to 2029.

2.  What are the key factors driving the growth of artificial intelligence (AI) in the life sciences market?

• The growth of Artificial Intelligence (AI) in the Life Sciences market is primarily driven by the increasing adoption of AI-driven solutions for drug discovery and development, the rising need for precision medicine and personalized treatment approaches, and the demand for advanced diagnostic tools to analyze complex biological data.

3.  What segments are covered in the global Artificial Intelligence (AI) in the Life Sciences market?

• The global Artificial Intelligence (AI) market in the Life Sciences is segmented based on product, application, end-user, and region.

4.  By Type, which segment will dominate the market by the end of 2029?

• The software segment will dominate the market by the end of 2029.

5.  Which region has the highest market share in Artificial Intelligence (AI) in the Life Sciences market?

• North America holds the highest share of the market.

 Some of the Key Market Players Are:

• AICURE
• APIXIO
• ATOMWISE INC.
• BENEVOLENTAI
• ENLITIC INC.
• NUMEDII INC.
• RECURSION
• ZEBRA TECHNOLOGIES CORP.

Browse Related Reports:

Global Markets for Artificial Intelligence in Drug Discovery: This report provides a comprehensive overview of AI in the drug discovery market, analyzing trends from 2020, recent estimates from 2021, and projecting compound annual growth rates through 2028. It focuses on market dynamics such as regulatory scenarios, drivers, restraints, and opportunities, highlighting the potential across applications including preclinical testing, target identification, candidate screening, lead optimization, drug repurposing, and De novo drug design. Therapeutic areas covered include oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and infectious diseases. Regional analysis spans North America, Europe, Asia-Pacific, and the Rest of the World, with detailed insights into key countries like the U.S., Germany, the U.K., Italy, France, Japan, China, and India.

Directly purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with [email protected]

About BCC Research

BCC Research provides objective, unbiased measurement, and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: [email protected],
Phone: +1 781-489-7301

For media inquiries, email [email protected] or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo – https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

SOURCE BCC Research LLC

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In